Literature DB >> 23426166

Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.

L Leanza, L Trentin, K A Becker, F Frezzato, M Zoratti, G Semenzato, E Gulbins, I Szabo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426166     DOI: 10.1038/leu.2013.56

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  33 in total

1.  State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.

Authors:  Malika Faouzi; John Starkus; Reinhold Penner
Journal:  Br J Pharmacol       Date:  2015-10-09       Impact factor: 8.739

Review 2.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

Review 3.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 4.  Ion Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk.

Authors:  Jerry J Fan; Xi Huang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 5.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

6.  Midazolam's Effects on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-lymphocytes.

Authors:  Ning-Ping Foo; Yu-Fan Liu; Ping-Ching Wu; Chung-Hsi Hsing; Bu-Miin Huang; Edmund-Cheung So
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

7.  Inhibition of Kv1.3 Channels in Human Jurkat T Cells by Xanthohumol and Isoxanthohumol.

Authors:  Justyna Gąsiorowska; Andrzej Teisseyre; Anna Uryga; Krystyna Michalak
Journal:  J Membr Biol       Date:  2015-02-17       Impact factor: 1.843

Review 8.  The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.

Authors:  Paolo Bernardi; Andrea Rasola; Michael Forte; Giovanna Lippe
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

9.  Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.

Authors:  E M Grössinger; L Weiss; S Zierler; S Rebhandl; P W Krenn; E Hinterseer; J Schmölzer; D Asslaber; S Hainzl; D Neureiter; A Egle; J Piñón-Hofbauer; T N Hartmann; R Greil; H H Kerschbaum
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

Review 10.  Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics.

Authors:  Umberto Banderali; Luigi Leanza; Najmeh Eskandari; Saverio Gentile
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.